We are live on ! Find out more
KA

Kooman & Associates Portfolio holdings

AUM $372M
1-Year Est. Return 22.32%
This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+22.32%
3 Year Est. Return
+59.9%
5 Year Est. Return
10 Year Est. Return
AUM
$202M
AUM Growth
+$17M
Cap. Flow
+$9.04M
Cap. Flow %
4.48%
Top 10 Hldgs %
88.73%
Holding
44
New
3
Increased
26
Reduced
12
Closed
2

Sector Composition

Rank Sector Weight
1 Technology 1.68%
2 Communication Services 0.75%
3 Healthcare 0.55%
4 Consumer Discretionary 0.51%
5 Consumer Staples 0.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
26
AbbVie
ABBV
$458B
$449K 0.22%
3,329
-207
-6% -$30.4K
AGG icon
27
iShares Core US Aggregate Bond ETF
AGG
$138B
$430K 0.21%
4,393
+265
+6% +$26.2K
WMT icon
28
Walmart Inc
WMT
$871B
$409K 0.2%
7,800
+111
+1% +$5.6K
IJR icon
29
iShares Core S&P Small-Cap ETF
IJR
$109B
$322K 0.16%
3,231
+145
+5% +$13.8K
DIS icon
30
Walt Disney
DIS
$165B
$299K 0.15%
3,350
+35
+1% +$3.32K
VZ icon
31
Verizon
VZ
$194B
$290K 0.14%
7,809
-550
-7% -$20.4K
VTEB icon
32
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.1B
$285K 0.14%
5,669
TSLA icon
33
Tesla
TSLA
$1.24T
$282K 0.14%
1,076
+61
+6% +$12.2K
MCD icon
34
McDonald's
MCD
$188B
$269K 0.13%
900
+6
+0.7% +$1.74K
CVX icon
35
Chevron
CVX
$388B
$247K 0.12%
1,568
+158
+11% +$25.3K
T icon
36
AT&T
T
$165B
$241K 0.12%
15,133
+983
+7% +$16.7K
GSK icon
37
GSK
GSK
$103B
$222K 0.11%
6,229
-47
-0.7% -$1.69K
JNJ icon
38
Johnson & Johnson
JNJ
$635B
$221K 0.11%
1,338
+38
+3% +$6.13K
NFLX icon
39
Netflix
NFLX
$292B
$215K 0.11%
+4,890
New +$180K
LLY icon
40
Eli Lilly
LLY
$1.07T
$210K 0.1%
+447
New +$187K
XOM icon
41
ExxonMobil
XOM
$651B
$203K 0.1%
1,895
+25
+1% +$2.73K
WMB icon
42
Williams Companies
WMB
$90.5B
$201K 0.1%
+6,174
New +$185K
TTE icon
43
TotalEnergies
TTE
$193B
-3,457
Closed -$204K
UPS icon
44
United Parcel Service
UPS
$97.6B
-1,046
Closed -$203K

Similar funds

Kooman & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Kooman & Associates held 44 positions worth $202M, up 9.2% from $185M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Kooman & Associates deployed $9.04M of net new capital in Q2 2023, opening 3 new positions and adding to 26 existing holdings. Its largest new stake was Eli Lilly: 447 shares worth $210K.

By sector, the portfolio is most concentrated in Technology at 1.7% of assets, up from 1.3% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $1.62M trimmed.

  • Kooman & Associates's largest Q2 2023 buy was Eli Lilly: 447 shares worth $210K.
  • Kooman & Associates added most to Dimensional US Core Equity Market ETF in Q2 2023, an estimated $4.14M increase.
  • Kooman & Associates's biggest Q2 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.62M.
  • Kooman & Associates fully exited TotalEnergies in Q2 2023, selling an estimated $204K.
  • Kooman & Associates's ten largest holdings make up 89% of its $202M portfolio in Q2 2023.
  • Kooman & Associates opened 3 new positions and closed 2 in Q2 2023.
  • Kooman & Associates's portfolio value rose 9.2% quarter-over-quarter to $202M.

Based on Kooman & Associates's 13F filing for Q2 2023, filed 21 Jul 2023.